Home

Treatment

Read time: 5 min

Satellite symposium

Targeting trace amine-associated receptors (TAARs) to treat schizophrenia

In this symposium titled ‘Novel TAARgets for stabilizing neural circuits in schizophrenia...

Read time: 4 min

Congress highlights

Integrate different strategies to break the vicious cycle

It is all too easy for a patient with migraine to slip into a vicious cycle of increasing acute...

Medication use and overuse in people with migraine

At EAN 2022, Gisela Terwindt, Professor of Neurology, Leiden University Medical Centre, Leiden, The...

Evolving treatments for migraine prevention

At EAN 2022, Cristina Tassorelli, Professor of Neurology, University of Pavia, Italy, discussed...

Challenges and impacts for people with migraine with regard to medication overuse headache

At EAN 2022, Henrik Schytz, Associate Professor of Neurology, Denmark Headache Center, Denmark,...

The distinguishing factors between medication overuse headache and chronic migraine

At EAN 2022, Gisela Terwindt, Professor of Neurology, Leiden University Medical Centre, Leiden, The...

Read time: 5 min

Satellite symposium

The glutamate model of psychosis

In the Keynote Session of the 35th ECNP Congress in Vienna, Austria (15th−18th Oct),...

Neurotoriun

Neurotorium is your new point of reference for educational content on psychiatry, neurology, and neuroscience.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

Progress in Mind Belux

Accept Cancel

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intended for health care professionals.

All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country